SCHEMBL7680169

SCHEMBL7680169

COC(=O)c1cc(C#N)cc2c1CCCC2

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
XDH P47989 1/20 0.44
SLC22A12 Q96S37 1/20 0.44
NLRP3 Q96P20 4/20 0.43
CXCR5 P32302 1/20 0.42
GAA P10253 3/20 0.40
KDM4E B2RXH2 6/20 0.39
ALDH1A1 P00352 5/20 0.39
HPGD P15428 4/20 0.39
HSD17B10 Q99714 3/20 0.39
CASP1 P29466 2/20 0.39
CASP7 P55210 2/20 0.39
MAPK10 P53779 1/20 0.39
KMT2A Q03164 2/20 0.39
NPC1 O15118 1/20 0.39
RAB9A P51151 1/20 0.39
NAMPT P43490 1/20 0.38
LMNA P02545 1/20 0.36
MAPT P10636 1/20 0.36
RXFP1 Q9HBX9 1/20 0.36
ACHE P22303 3/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4262554 0.81 XDH (0.58) XDHSLC22A12NLRP3CXCR5KDM4E
SCHEMBL4266407 0.80 XDH (0.47) XDHSLC22A12NLRP3CXCR5KDM4E
SCHEMBL7677467 0.78 CA12 (0.46) NLRP3CXCR5GAAKDM4EALDH1A1
SCHEMBL30995649 0.78 CA12 (0.46) NLRP3CXCR5GAAKDM4EALDH1A1
SCHEMBL4263054 0.78 XDH (0.61) XDHSLC22A12NLRP3CXCR5KDM4E
SCHEMBL4260569 0.77 CXCR5 (0.39) NLRP3CXCR5KDM4EALDH1A1HPGD
SCHEMBL19124992 0.77 ACHE (0.39) NLRP3GAAKDM4EALDH1A1HPGD
SCHEMBL30995655 0.77 ACHE (0.39) NLRP3GAAKDM4EALDH1A1HPGD
SCHEMBL7678090 0.77 CXCR5 (0.44) NLRP3CXCR5GAAKDM4EALDH1A1
SCHEMBL4258057 0.77 ACHE (0.44) NLRP3GAAKDM4EALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6403601-B1 TREATMENT OF ASTHMA, ANXIETY, DEPRESSION, EMESIS, URINARY INCONTINENCE AND RELATED CONDITIONS. ASTRAZENECA AB (SE) 2002-06-11 US disclosed
EP-1137637-A1 N-(2-PHENYL-4-PIPERIDINYLBUTYL)-5,6,7,8-TETRAHYDRO-1-NAPHTHALENECARBOXAMIDES AND THEIR USE AS NEUROKININ 1 (NK1) AND/OR NEUROKININ 2 (NK2) RECEPTOR ANTAGONISTS AstraZeneca AB (SE) 2001-10-04 EP disclosed
WO-2000034243-A1 N-(2-PHENYL-4-PIPERIDINYBUTYL)-5,6,7,8-TETRAHYDRO-1-NAPHTHALENECARBOXAMIDES AND THEIR USE AS NEUROKININ 1 (NK1) AND/OR NEUROKININ 2 (NK2) RECEPTOR ANTAGONISTS ASTRAZENECA AB (SE) 2000-06-15 WO disclosed